Management of metastatic kidney cancer

This e-course will show the latest indications for the medical treatment of metastatic renal cell carcinoma (RCC) according to the evidence showed in literature and at the ASCO GU 2023 congress.

Published Tue, 4 Apr 2023
E CourseKidney CancerOncology
Organiser European School of Urology
Duration Approx. 60 minutes

Lectures will highlight the first-line and second-line treatment in this stage of the disease. The last part of the e-course will focus on the clinical management of adverse events following systemic treatment in metastatic RCC.

CME: This e-course is accredited with 1 European CME credit (ECMEC®) upon completion.


This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection.

Contact our organiser

European School of Urology